Christopher Betti, PhD

Patent Lawyer at Morgan, Lewis & Bockius LLP

Speaker

Chris is a registered patent lawyer who helps biotechnology and pharmaceutical companies protect, defend, and commercialize innovation in the biologics space, with a particular focus on antibodies, antibody-based therapeutics, biosimilars, and AI assisted drug discovery. His practice spans the full patent lifecycle, from strategic patent prosecution and global portfolio development to pre-litigation counseling, freedom-to-operate analysis, validity and infringement opinions, due diligence, licensing, lifecycle management, and patent litigation. He regularly work with innovators and biosimilar applicants on complex issues arising under the Biologics Price Competition and Innovation Act, including patent strategy, regulatory considerations, and litigation-readiness for biologic and biosimilar products.